Accrued Issuable Equity (Details Narrative) - USD ($) |
12 Months Ended | |||||
---|---|---|---|---|---|---|
Apr. 09, 2018 |
Apr. 03, 2018 |
Dec. 01, 2017 |
Sep. 26, 2017 |
Dec. 31, 2017 |
Aug. 29, 2017 |
|
Warrants to purchase shares of common stock | 1,030,115 | |||||
Issuance of share common stock | 25,669 | 11,503 | ||||
Issuance of share common stock, value | $ 70,000 | |||||
Loss on inducement expense | $ 6,500,000 | |||||
Fair value adjustment of warrant liability | $ 247,360 | |||||
Warrant Holders [Member] | ||||||
Warrants to purchase shares of common stock | 726,504 | 726,704 | ||||
Grant date fair value of warrants | $ 1,500,000 | |||||
Issuance of share common stock | 711,041 | 711,041 | 711,041 | |||
Issuance of share common stock, value | $ 8,000,000 | |||||
Aggregate fair value of common stock | $ 4,200,000 | |||||
Fair value adjustment of warrant liability | $ 3,800,000 | |||||
Executive Chairman [Member] | ||||||
Warrants to purchase shares of common stock | 15,000 | 3,100,000 | ||||
Replacement of warrants accrued | $ 55,046 |
X | ||||||||||
- Definition Aggregate fair value of common stock. No definition available.
|
X | ||||||||||
- Definition Grant date fair value of warrants. No definition available.
|
X | ||||||||||
- Definition Loss on inducement expense. No definition available.
|
X | ||||||||||
- Definition Replacement of warrants accrued. No definition available.
|
X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|